Dados B3 › BMOB3 × TOTS3
BMOB3 × TOTS3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BMOB3 | TOTS3 | year |
|---|---|---|---|
| ROE | 14.8% | 18.2% | 2025 |
| ROIC | 19.3% | 17.8% | 2025 |
| ROA | 9.2% | 10.2% | 2025 |
| Gross margin | 25.7% | 70.3% | 2025 |
| EBIT margin | 8.5% | 19.5% | 2025 |
| Net margin | 9.5% | 16.0% | 2025 |
| Net debt/EBITDA | -1.61x | 0.03x | 2025 |
| Current ratio | 1.86x | 1.96x | 2025 |
| Revenue growth (1y) | 13.2% | 17.4% | 2025 |
| Revenue growth (5y CAGR) | 58.1% | 17.3% | 2025 |
| Piotroski F-Score | 5/9 | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BMOB3 | TOTS3 | year |
|---|---|---|---|
| P/E | 12.55x | 25.47x | 2025 |
| P/B | 2.06x | 4.45x | 2025 |
| EV/EBITDA | 7.62x | 15.55x | 2025 |
| FCF yield | 3.1% | 4.2% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:30 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:30 UTC. If this does not match /saude, you are reading a cached copy.